Evidence map›Paper›PMID 38509957›Full record

ArticleHeliyon2024

Evaluation of antibacterial activity and influencing factors of normal and nanostructured copper-based materials.

Jiahao Li, Luhua Lu, Yongzhong Jiang, Fei Tang, Qiao Wu, He Liu, Qili Zeng

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jiahao LiHubei Province Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China.
Luhua LuFaculty of Materials Science and Chemistry, China University of Geosciences, Wuhan, 430070, China.
Yongzhong JiangHubei Province Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China.
Fei TangHuazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
Qiao WuFaculty of Materials Science and Chemistry, China University of Geosciences, Wuhan, 430070, China.
He LiuTianjin Centers for Disease Control and Prevention, Tianjin, 300011, China.
Qili ZengHubei Province Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China.
China University of Geosciences · CNHuazhong University of Science and Technology · CNTianjin Centers for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Copper-based materials have garnered extensive recognition for their effective nature against microorganisms and their minimal toxicity. However, the evaluation for their antibacterial activity is still in its nascent stages, and the evaluation results based on existing criteria are not representative of real-world application. Aim: To evaluate the antibacterial activity and primary determinants of influence of copper-based materials in order to investigate their practical antibacterial activity and potential mechanisms of such materials. Methods: Findings: Following 1 h of exposure to 37 °C and 90% relative humidity, Conclusion: While copper-based materials exhibit robust antibacterial activity as determined by standard assays, their efficacy in real-world applications is subject to various influencing mechanisms. In order to objectively evaluate the antibacterial activity of copper-based materials and provide precise guidance for their development and practical application, it is essential to regulate test conditions with targeted.

Indexed as

Antibacterial performanceInfluence factorNanomaterials

Identifiers

PMID38509957
PMCPMC10950676
OpenAlexW4392623831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.